Analysis of downstream targets in pancreatic cancer cell lines identified that MEK/ERK/TSC/mTOR signaling is dependent on ALDH1A3 function and high expression of ALDH1A3 is associated with an aggressive subtype of PDAC (34). This evidence concerns the gene ALDH1A3 and pancreatic neoplasm.